Comorbidities, multimorbidity and COVID-19
The influence of comorbidities on COVID-19 outcomes has been recognized since the
earliest days of the pandemic. But establishing causality and determining underlying …
earliest days of the pandemic. But establishing causality and determining underlying …
The impact of the COVID-19 pandemic on respiratory syncytial virus infection: a narrative review
YC Chuang, KP Lin, LA Wang, TK Yeh… - Infection and Drug …, 2023 - Taylor & Francis
Respiratory syncytial virus (RSV) is one of the most common respiratory viruses. It not only
affects young children but also the elderly and immunocompromised patients. After the …
affects young children but also the elderly and immunocompromised patients. After the …
Assessment of COVID-19 as the underlying cause of death among children and young people aged 0 to 19 years in the US
Importance COVID-19 was the underlying cause of death for more than 940 000 individuals
in the US, including at least 1289 children and young people (CYP) aged 0 to 19 years, with …
in the US, including at least 1289 children and young people (CYP) aged 0 to 19 years, with …
Supersulphides provide airway protection in viral and chronic lung diseases
T Matsunaga, H Sano, K Takita, M Morita… - Nature …, 2023 - nature.com
Supersulphides are inorganic and organic sulphides with sulphur catenation with diverse
physiological functions. Their synthesis is mainly mediated by mitochondrial cysteinyl-tRNA …
physiological functions. Their synthesis is mainly mediated by mitochondrial cysteinyl-tRNA …
Risk factors of severe COVID-19: a review of host, viral and environmental factors
The clinical course and outcome of COVID-19 are highly variable, ranging from
asymptomatic infections to severe disease and death. Understanding the risk factors of …
asymptomatic infections to severe disease and death. Understanding the risk factors of …
Severe COVID-19 outcomes in pediatrics: An observational cohort analysis comparing Alpha, Delta, and Omicron variants
A Bahl, N Mielke, S Johnson, A Desai… - The Lancet Regional …, 2023 - thelancet.com
Objective COVID-19 can rarely lead to severe illness in pediatric patients. The aim of this
study was to determine if severe outcomes in pediatric COVID-19 have changed over the …
study was to determine if severe outcomes in pediatric COVID-19 have changed over the …
[HTML][HTML] Global SARS-CoV-2 genomic surveillance: What we have learned (so far)
The COVID-19 pandemic has brought significant challenges for genomic surveillance
strategies in public health systems worldwide. During the past thirty-four months, many …
strategies in public health systems worldwide. During the past thirty-four months, many …
COVID-19 and respiratory virus co-infections: a systematic review of the literature
HC Maltezou, A Papanikolopoulou, S Vassiliu… - Viruses, 2023 - mdpi.com
Τhe COVID-19 pandemic highly impacted the circulation, seasonality, and morbidity burden
of several respiratory viruses. We reviewed published cases of SARS-CoV-2 and respiratory …
of several respiratory viruses. We reviewed published cases of SARS-CoV-2 and respiratory …
Immune interference in effectiveness of influenza and COVID-19 vaccination
Y Xie, X Tian, X Zhang, H Yao, N Wu - Frontiers in immunology, 2023 - frontiersin.org
Vaccines are known to function as the most effective interventional therapeutics for
controlling infectious diseases, including polio, smallpox, rabies, tuberculosis, influenza and …
controlling infectious diseases, including polio, smallpox, rabies, tuberculosis, influenza and …
The impact of COVID-19 and COVID vaccination on cardiovascular outcomes
COVID-19 is an independent risk factor for cardiovascular disease. COVID-19 vaccination
may prevent this, but in some cases, COVID-19 vaccination may cause myocarditis or …
may prevent this, but in some cases, COVID-19 vaccination may cause myocarditis or …